As Invitrogen Pens Biomarker Pact, Downstream Objectives Take Shape | GenomeWeb

As Invitrogen starts to focus on its recently announced collaboration with the Fred Hutchinson Cancer Research Center, its second biomarker pact within the past year with a major cancer center, the firm has taken one step closer to entering the molecular diagnostics and pharmacogenomic markets and adopting what one official calls a "patient-centric" view.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: genes involved in histone deacetylation in Arabidopsis, effects of pathogenic presenilin-1 mutations, and more.

After a study finds DNA from antibiotic-resistant bacteria in Beijing smog, residents there worry, according to the New York Times.

Canada begins its search for a chief government science advisor, Nature News reports.

A company is using facial recognition tools to identify genetic disorders from pictures, Technology Review reports.